Deregulation of NR2E3, an orphan nuclear receptor, by benzo(a)pyrene-induced oxidative stress is associated with histone modification status change of the estrogen receptor gene promoter.

[1]  H. Wang,et al.  Chronic Exposure to Combined Carcinogens Enhances Breast Cell Carcinogenesis with Mesenchymal and Stem-Like Cell Properties , 2014, PloS one.

[2]  H. Xu,et al.  The Crystal Structure of the Orphan Nuclear Receptor NR2E3/PNR Ligand Binding Domain Reveals a Dimeric Auto-Repressed Conformation , 2013, PloS one.

[3]  P. Hodder,et al.  In pursuit of synthetic modulators for the orphan retina-specific nuclear receptor NR2E3. , 2013, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[4]  V. Androutsopoulos,et al.  Benzo[a]pyrene sensitizes MCF7 breast cancer cells to induction of G1 arrest by the natural flavonoid eupatorin-5-methyl ether, via activation of cell signaling proteins and CYP1-mediated metabolism. , 2012, Toxicology letters.

[5]  G. Mills,et al.  Reconstruction of nuclear receptor network reveals that NR2E3 is a novel upstream regulator of ESR1 in breast cancer , 2012, EMBO molecular medicine.

[6]  P. Ahlquist,et al.  Orphan Nuclear Receptor PNR/NR2E3 Stimulates p53 Functions by Enhancing p53 Acetylation , 2011, Molecular and Cellular Biology.

[7]  K. Ramos,et al.  Reactivation of L1 retrotransposon by benzo(a)pyrene involves complex genetic and epigenetic regulation , 2011, Epigenetics.

[8]  T. Ohura,et al.  Inhibitory effects of chrysoeriol on DNA adduct formation with benzo[a]pyrene in MCF-7 breast cancer cells. , 2010, Toxicology.

[9]  R. Schüle,et al.  Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology. , 2010, Carcinogenesis.

[10]  D. Schorderet,et al.  NR2E3 mutations in enhanced S‐cone sensitivity syndrome (ESCS), Goldmann‐Favre syndrome (GFS), clumped pigmentary retinal degeneration (CPRD), and retinitis pigmentosa (RP) , 2009, Human mutation.

[11]  Peng Huang,et al.  Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? , 2009, Nature Reviews Drug Discovery.

[12]  P. Gouras,et al.  Phenotypic features of patients with NR2E3 mutations. , 2009, Archives of ophthalmology.

[13]  P. Hodor,et al.  Dual role of Nr2e3 in photoreceptor development and maintenance. , 2008, Experimental eye research.

[14]  David R F Carter,et al.  Genome-wide H3K9 Histone Acetylation Profiles Are Altered in Benzopyrene-treated MCF7 Breast Cancer Cells* , 2008, Journal of Biological Chemistry.

[15]  S. Daiger,et al.  The Gly56Arg mutation in NR2E3 accounts for 1-2% of autosomal dominant retinitis pigmentosa. , 2007, Molecular vision.

[16]  M. Cronin,et al.  Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  O. Ahmad,et al.  The photoreceptor-specific nuclear receptor Nr2e3 interacts with Crx and exerts opposing effects on the transcription of rod versus cone genes. , 2005, Human molecular genetics.

[18]  J. Nathans,et al.  The Rod Photoreceptor-Specific Nuclear Receptor Nr2e3 Represses Transcription of Multiple Cone-Specific Genes , 2005, The Journal of Neuroscience.

[19]  Yang Shi,et al.  Histone Demethylation Mediated by the Nuclear Amine Oxidase Homolog LSD1 , 2004, Cell.

[20]  Hemant Khanna,et al.  Photoreceptor-specific nuclear receptor NR2E3 functions as a transcriptional activator in rod photoreceptors. , 2004, Human molecular genetics.

[21]  Peng Huang,et al.  ROS stress in cancer cells and therapeutic implications. , 2004, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[22]  A. Burdick,et al.  Benzo(a)pyrene quinones increase cell proliferation, generate reactive oxygen species, and transactivate the epidermal growth factor receptor in breast epithelial cells. , 2003, Cancer research.

[23]  D. Sharon,et al.  Shared mutations in NR2E3 in enhanced S-cone syndrome, Goldmann-Favre syndrome, and many cases of clumped pigmentary retinal degeneration. , 2003, Archives of ophthalmology.

[24]  A. V. Cideciyan,et al.  The nuclear receptor NR2E3 plays a role in human retinal photoreceptor differentiation and degeneration , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[25]  M. Spitz,et al.  Sensitivity to benzo(a)pyrene diol-epoxide associated with risk of breast cancer in young women and modulation by glutathione S-transferase polymorphisms: a case-control study. , 2001, Cancer research.

[26]  M. Tang,et al.  Methylated CpG dinucleotides are the preferential targets for G-to-T transversion mutations induced by benzo[a]pyrene diol epoxide in mammalian cells: similarities with the p53 mutation spectrum in smoking-associated lung cancers. , 2001, Cancer research.

[27]  J. Naggert,et al.  Excess cone cell proliferation due to lack of a functional NR2E3 causes retinal dysplasia and degeneration in rd7/rd7 mice. , 2001, Human molecular genetics.

[28]  N. Rothman,et al.  Analysis of 200 food items for benzo[a]pyrene and estimation of its intake in an epidemiologic study. , 2001, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[29]  T. Roderick,et al.  A deletion in a photoreceptor-specific nuclear receptor mRNA causes retinal degeneration in the rd7 mouse. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[30]  T. Penning,et al.  Genotoxic polycyclic aromatic hydrocarbon ortho-quinones generated by aldo-keto reductases induce CYP1A1 via nuclear translocation of the aryl hydrocarbon receptor. , 2000, Cancer research.

[31]  J. Freudenheim,et al.  Risk of premenopausal breast cancer in association with occupational exposure to polycyclic aromatic hydrocarbons and benzene. , 1999, Scandinavian journal of work, environment & health.

[32]  C K Osborne,et al.  Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  K. Umesono,et al.  Identification of a photoreceptor cell-specific nuclear receptor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[34]  T. Penning,et al.  Isoform-specific induction of a human aldo-keto reductase by polycyclic aromatic hydrocarbons (PAHs), electrophiles, and oxidative stress: implications for the alternative pathway of PAH activation catalyzed by human dihydrodiol dehydrogenase. , 1999, Cancer research.

[35]  D. Allred,et al.  Prognostic and predictive factors in breast cancer by immunohistochemical analysis. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[36]  P. Boffetta,et al.  Cancer risk from occupational and environmental exposure to polycyclic aromatic hydrocarbons , 1997, Cancer Causes & Control.

[37]  J Isola,et al.  Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  K. Keyomarsi,et al.  Expression of cytochromes P450 in human breast tissue and tumors. , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[39]  Donghui Li,et al.  Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology. , 1996, Cancer research.

[40]  S. Baylin,et al.  Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. , 1994, Cancer research.

[41]  C. Redmond,et al.  A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. , 1989, The New England journal of medicine.

[42]  O. Pelkonen,et al.  Mutagenicity studies of different polycyclic aromatic hydrocarbons: the significance of enzymatic factors and molecular structure. , 1987, Carcinogenesis.

[43]  M. Stampfer,et al.  Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo[a]pyrene. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[44]  D. Nebert,et al.  Metabolism of polycyclic aromatic hydrocarbons: etiologic role in carcinogenesis. , 1982, Pharmacological reviews.

[45]  H. Gelboin.  Benzo[alpha]pyrene metabolism, activation and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes. , 1980, Physiological reviews.

[46]  S. Hecht,et al.  Tobacco smoke carcinogens and breast cancer , 2002, Environmental and molecular mutagenesis.

[47]  S. Safe,et al.  Modulation of gene expression and endocrine response pathways by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds. , 1995, Pharmacology & therapeutics.